Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy

Journal of Cardiac Failure

Volumn 21, Issue 7, 2015, Pages 541-547

  Penn, Justin ^a   Goldenberg, Ilan ^b,c   McNitt, Scott ^b   Polonsky, Bronislava ^b   Ruwald, Martin H ^b   Zareba, Wojciech ^b   Moss, Arthur J ^b   Alexis, Jeffrey D ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

angiotensin receptor blocker; angiotensin converting enzyme inhibitor; diuretic; Heart failure; resynchronization

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEATH; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; QRS COMPLEX; TREATMENT OUTCOME; DRUG EFFECTS; ECHOCARDIOGRAPHY; HEART STROKE VOLUME; MIDDLE AGED; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; TACHYCARDIA, VENTRICULAR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; DIURETICS; DRUG UTILIZATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84943582930     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.03.006     Document Type: Article

References (24)

1. A.S. Go, D. Mozaffarian, V.L. Roger, and et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. P.S. Jhund, K. Macintyre, C.R. Simpson, and et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people Circulation 119 2009 515 523
3. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
4. CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1987 1429 1435
5. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
8. J.N. Cohn, and G. Tognoni Valsartan Heart Failure Trial I. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
9. M. Packer, M.R. Bristow, J.N. Cohn, et al. US Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
10. M. Packer, A.J. Coats, M.B. Fowler, and et al. Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
11. M.A. Pfeffer, K. Swedberg, C.B. Granger, and et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
12. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
13. M. Domanski, J. Norman, B. Pitt, and et al. Diuretic use, progressive heart failure, and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD) J Am Coll Cardiol 42 2003 705 708
14. M. Domanski, X. Tian, M. Haigney, and B. Pitt Diuretic use, progressive heart failure, and death in patients in the DIG study J Card Fail 12 2006 327 332
15. S. Eshaghian, T.B. Horwich, and G.C. Fonarow Relation of loop diuretic dose to mortality in advanced heart failure Am J Cardiol 97 2006 1759 1764
16. M.R. Bristow, L.A. Saxon, J. Boehmer, and et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
17. J.G. Cleland, J.C. Daubert, E. Erdmann, and et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
18. A.J. Moss, W.J. Hall, D.S. Cannom, and et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
19. R.J. van Bommel, J.J. Bax, W.T. Abraham, and et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis Eur Heart J 30 2009 2470 2477
20. C. Ypenburg, R.J. van Bommel, C.J. Borleffs, and et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up J Am Coll Cardiol 53 2009 483 490
21. A.J. Moss, M.W. Brown, D.S. Cannom, and et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 2005 34 43
22. J. Bayliss, M. Norell, R. Canepa-Anson, G. Sutton, and P. Poole-Wilson Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics Br Heart J 57 1987 17 22
23. G.S. Francis, R.M. Siegel, S.R. Goldsmith, M.T. Olivari, T.B. Levine, and J.N. Cohn Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis Ann Intern Med 103 1985 1 6
24. S.R. Goldsmith, G. Francis, and J.N. Cohn Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure Am J Cardiol 64 1989 1382 1385